Clinical Trial Update: Observe Change in Nasal Swab DRD2 Gene Expression in Restless Legs Syndrome (RLS) Patients on Prolonged Dopamine Agonist Treatment

View source ↗

Summary

This clinical trial update investigates whether DRD2 gene expression changes in nasal swabs from patients with restless legs syndrome who are on prolonged dopam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Snippet

Sponsor: HBC Immunology Inc | Conditions: Restless Leg Syndrome (RLS) | Status: RECRUITING